Successful Phase 3 Trials Propel Innovent’s Mazdutide into China’s Obesity Market

January 9, 2024

Tetra Bio-Pharma’s ARDS-003 combined with antiviral drugs significantly reduces viral replication

June 25, 2021

Novo Reports Mixed Phase 2 Results for Coramitug in Transthyretin Amyloidosis Cardiomyopathy

November 11, 2025

Must Read

Top 10 High-Impact Careers Defining the Future of Life Sciences

May 1, 2026

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

May 1, 2026

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

May 1, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Novartis and PTC Advance Huntington’s Drug Votoplam to Phase 3 Following Mid-Stage Data

Oruka Therapeutics Reports Phase 2a Psoriasis Data Showing 63.5% Skin Clearance with ORKA-001

Chiesi to Acquire KalVista for $1.9 Billion, Adding Oral HAE Therapy Ekterly

Teva Pens Deal Worth Over $700M to Buy Emalex

Lilly Continues Good M&A Run With $2.3B Deal For JAK Inhibitor Biotech Ajax

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 High-Impact Careers Defining the Future of Life Sciences

Top 10 Pharma Companies Leading Innovation in Drug Development (2026)

Top 10 Breakthrough Therapies Shaping the Future of Medicine (2026)

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Clinical

Pfizer’s newly acquired Metsera reports 14% weight loss, “class-leading tolerability” for lead GLP-1 candidate

Editor Picks

Successful Phase 3 Trials Propel Innovent’s Mazdutide into China’s Obesity Market

Tetra Bio-Pharma’s ARDS-003 combined with antiviral drugs significantly reduces viral replication

Novo Reports Mixed Phase 2 Results for Coramitug in Transthyretin Amyloidosis Cardiomyopathy

Must Read

Top 10 High-Impact Careers Defining the Future of Life Sciences

In a late-stage trial, Intellia’s gene treatment for rare condition reduces swelling attacks

Boehringer Reports Phase 3 Data on Survodutide Showing 16.6% Weight Loss at Week 76

Hot Topics

About Us

Follow Us